A thrombin-cross-reactive anticardiolipin antibody binds to and inhibits the anticoagulant function of activated

Kwan-Ki Hwang1, Cheng-De Yang, Weihong Yan

  • 1Medicine/Rheumatology, University of California, Los Angeles, CA 90095-1670, USA. hwangkk@ucla.edu

Insights

Some anticardiolipin antibodies (aCL) bind to protein C (PC) and activated PC (APC). One specific aCL inhibited APC

Area of Science:

  • Immunology
  • Hematology
  • Thrombosis Research

Background:

  • Anticardiolipin antibodies (aCL) are associated with thrombosis.
  • The interaction of aCL with protein C (PC) and activated PC (APC) is not fully understood.

Purpose of the Study:

  • To investigate if thrombin-reactive aCL bind to PC and/or APC.
  • To determine if these binding aCL affect PC activation or APC function.

Main Methods:

  • Studied patient-derived monoclonal aCL reactivity with PC and APC.
  • Assessed the impact of reactive antibodies on PC activation and APC activity in plasma.

Main Results:

  • Five of five thrombin-reactive monoclonal aCL bound to PC and APC.
  • One antiprothrombin antibody with aCL activity also bound to PC and APC.
  • One antibody (CL15) inhibited the anticoagulant function of APC.

Conclusions:

  • Thrombin-reactive aCL frequently bind to PC and APC in antiphospholipid syndrome.
  • Some APC-reactive aCL may inhibit APC's anticoagulant function, potentially promoting thrombosis.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...